Literature DB >> 28629923

Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP∼T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea.

Yun-Kyung Kim1, Emmanuel Vidor2, Hwang Min Kim3, Son Moon Shin4, Kyung-Yil Lee5, Sung-Ho Cha6, Sang Hyuk Ma7, Dong Ho Kim8, Jin Lee9, Su Eun Park10, Hyunju Lee11, Jong-Duk Kim12, Ki Hwan Kim13, Kyung-Hyo Kim14, Jong-Hyun Kim15.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28629923     DOI： 10.1016/j.vaccine.2017.05.062

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  3 in total

Review 1.  DTaP-IPV-HepB-Hib Vaccine (Hexyon®): An Updated Review of its Use in Primary and Booster Vaccination.

Authors:  Yahiya Y Syed
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.930

2.  Economic impact of switching from partially combined vaccine "Pentaxim® and hepatitis B" to fully combined vaccine "Hexaxim®" in the Malaysian National Immunization Program.

Authors:  Syed Mohamed Aljunid; Lama Al Bashir; Aniza Binti Ismail; Azimatun Noor Aizuddin; S A Zafirah Abdul Rashid; Amrizal Muhammad Nur
Journal:  BMC Health Serv Res       Date:  2022-01-05       Impact factor: 2.655

3.  Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants.

Authors:  Hye-Kyung Cho; Su Eun Park; Yae-Jean Kim; Dae Sun Jo; Yun-Kyung Kim; Byung-Wook Eun; Taek-Jin Lee; Jina Lee; Hyunju Lee; Ki Hwan Kim; Eun Young Cho; Jong Gyun Ahn; Eun Hwa Choi
Journal:  Clin Exp Pediatr       Date:  2021-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.